CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION – Trademark Portfolio

Entity Type: 03

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 3 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include LIQUN, MODERN, and DAHONGYING. The owner is based in Zhejiang Province.

No. 288 Jianguo Nan Road

Zhejiang Province , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LIQUN
LIQUN
Registered 2001
MODERN
MODERN
Registered 1997

Trademark Classifications

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (3 filings)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION have?

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION file in?

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION files trademarks across 1 Nice Classification class. The most active classes are Class 34 (Smokers Articles). Class 34 covers tobacco; smokers articles; matches.

What are CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION's most well-known trademarks?

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION's registered trademark portfolio includes well-known marks such as LIQUN, MODERN, and DAHONGYING. These are among 3 currently registered trademarks in the portfolio.

What is CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION's trademark registration success rate?

CHINA TOBACCO ZHEJIANG INDUSTRIAL CORPORATION has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.